CHK2_HUMAN - dbPTM
CHK2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CHK2_HUMAN
UniProt AC O96017
Protein Name Serine/threonine-protein kinase Chk2
Gene Name CHEK2
Organism Homo sapiens (Human).
Sequence Length 543
Subcellular Localization Isoform 2: Nucleus. Isoform 10 is present throughout the cell.
Isoform 4: Nucleus.
Isoform 7: Nucleus.
Isoform 9: Nucleus.
Isoform 12: Nucleus.
Nucleus, PML body. Nucleus, nucleoplasm. Recruited into PML bodies together with TP53.
Protein Description Serine/threonine-protein kinase which is required for checkpoint-mediated cell cycle arrest, activation of DNA repair and apoptosis in response to the presence of DNA double-strand breaks. May also negatively regulate cell cycle progression during unperturbed cell cycles. Following activation, phosphorylates numerous effectors preferentially at the consensus sequence [L-X-R-X-X-S/T]. Regulates cell cycle checkpoint arrest through phosphorylation of CDC25A, CDC25B and CDC25C, inhibiting their activity. Inhibition of CDC25 phosphatase activity leads to increased inhibitory tyrosine phosphorylation of CDK-cyclin complexes and blocks cell cycle progression. May also phosphorylate NEK6 which is involved in G2/M cell cycle arrest. Regulates DNA repair through phosphorylation of BRCA2, enhancing the association of RAD51 with chromatin which promotes DNA repair by homologous recombination. Also stimulates the transcription of genes involved in DNA repair (including BRCA2) through the phosphorylation and activation of the transcription factor FOXM1. Regulates apoptosis through the phosphorylation of p53/TP53, MDM4 and PML. Phosphorylation of p53/TP53 at 'Ser-20' by CHEK2 may alleviate inhibition by MDM2, leading to accumulation of active p53/TP53. Phosphorylation of MDM4 may also reduce degradation of p53/TP53. Also controls the transcription of pro-apoptotic genes through phosphorylation of the transcription factor E2F1. Tumor suppressor, it may also have a DNA damage-independent function in mitotic spindle assembly by phosphorylating BRCA1. Its absence may be a cause of the chromosomal instability observed in some cancer cells. Promotes the CCAR2-SIRT1 association and is required for CCAR2-mediated SIRT1 inhibition. [PubMed: 25361978]
Protein Sequence MSRESDVEAQQSHGSSACSQPHGSVTQSQGSSSQSQGISSSSTSTMPNSSQSSHSSSGTLSSLETVSTQELYSIPEDQEPEDQEPEEPTPAPWARLWALQDGFANLECVNDNYWFGRDKSCEYCFDEPLLKRTDKYRTYSKKHFRIFREVGPKNSYIAYIEDHSGNGTFVNTELVGKGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGAETTKRPAVCAAVL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
3Ubiquitination-----MSRESDVEAQ
-----CCCHHHHHHH
46.2529967540
12PhosphorylationSDVEAQQSHGSSACS
HHHHHHHHHCCCCCC
20.1017918214
15PhosphorylationEAQQSHGSSACSQPH
HHHHHHCCCCCCCCC
14.8917918214
19PhosphorylationSHGSSACSQPHGSVT
HHCCCCCCCCCCCCC
46.6016205633
24PhosphorylationACSQPHGSVTQSQGS
CCCCCCCCCCCCCCC
20.9617918214
26PhosphorylationSQPHGSVTQSQGSSS
CCCCCCCCCCCCCCC
24.9710973490
28PhosphorylationPHGSVTQSQGSSSQS
CCCCCCCCCCCCCCC
27.4310973490
33PhosphorylationTQSQGSSSQSQGISS
CCCCCCCCCCCCCCC
35.2320160490
35PhosphorylationSQGSSSQSQGISSSS
CCCCCCCCCCCCCCC
32.1120160490
39PhosphorylationSSQSQGISSSSTSTM
CCCCCCCCCCCCCCC
30.8717918214
40PhosphorylationSQSQGISSSSTSTMP
CCCCCCCCCCCCCCC
26.7917918214
41PhosphorylationQSQGISSSSTSTMPN
CCCCCCCCCCCCCCC
30.7417918214
42PhosphorylationSQGISSSSTSTMPNS
CCCCCCCCCCCCCCC
28.4617918214
43PhosphorylationQGISSSSTSTMPNSS
CCCCCCCCCCCCCCC
30.1117918214
44PhosphorylationGISSSSTSTMPNSSQ
CCCCCCCCCCCCCCC
25.3417918214
45PhosphorylationISSSSTSTMPNSSQS
CCCCCCCCCCCCCCC
36.4117918214
50PhosphorylationTSTMPNSSQSSHSSS
CCCCCCCCCCCCCCC
40.5010973490
52PhosphorylationTMPNSSQSSHSSSGT
CCCCCCCCCCCCCCC
31.7817918214
55PhosphorylationNSSQSSHSSSGTLSS
CCCCCCCCCCCCCCC
28.3117918214
58UbiquitinationQSSHSSSGTLSSLET
CCCCCCCCCCCCEEE
32.4029967540
62PhosphorylationSSSGTLSSLETVSTQ
CCCCCCCCEEEECHH
33.0816481012
65PhosphorylationGTLSSLETVSTQELY
CCCCCEEEECHHHHC
25.6717918214
66UbiquitinationTLSSLETVSTQELYS
CCCCEEEECHHHHCC
4.2129967540
67PhosphorylationLSSLETVSTQELYSI
CCCEEEECHHHHCCC
31.6217918214
68PhosphorylationSSLETVSTQELYSIP
CCEEEECHHHHCCCC
23.0221731742
73PhosphorylationVSTQELYSIPEDQEP
ECHHHHCCCCCCCCC
44.2716481012
119UbiquitinationNYWFGRDKSCEYCFD
CCEECCCCCCCEECC
56.4929967540
120PhosphorylationYWFGRDKSCEYCFDE
CEECCCCCCCEECCC
19.2325159151
123PhosphorylationGRDKSCEYCFDEPLL
CCCCCCCEECCCHHH
11.6227732954
131UbiquitinationCFDEPLLKRTDKYRT
ECCCHHHHCCHHCCC
62.0229967540
140PhosphorylationTDKYRTYSKKHFRIF
CHHCCCCCHHHHEEE
34.3218948271
153AcetylationIFREVGPKNSYIAYI
EEHHHCCCCCEEEEE
53.2326051181
163 (in isoform 9)Phosphorylation-25.4724719451
164PhosphorylationIAYIEDHSGNGTFVN
EEEEEECCCCCEEEE
46.4020126263
174UbiquitinationGTFVNTELVGKGKRR
CEEEECEECCCCCCC
6.0729967540
174 (in isoform 9)Ubiquitination-6.07-
192PhosphorylationNNSEIALSLSRNKVF
CCCHHEEEECCCCEE
18.4424719451
194PhosphorylationSEIALSLSRNKVFVF
CHHEEEECCCCEEEE
30.3617081983
204 (in isoform 2)Phosphorylation-4.2020049867
205PhosphorylationVFVFFDLTVDDQSVY
EEEEEEEECCCCCCC
24.5920126263
210PhosphorylationDLTVDDQSVYPKALR
EEECCCCCCCCHHHH
30.5220126263
223UbiquitinationLRDEYIMSKTLGSGA
HHCHHHHHCCCCCCC
16.9629967540
224UbiquitinationRDEYIMSKTLGSGAC
HCHHHHHCCCCCCCC
30.3229967540
225PhosphorylationDEYIMSKTLGSGACG
CHHHHHCCCCCCCCC
29.1025056879
235AcetylationSGACGEVKLAFERKT
CCCCCHHHHHHCCCC
29.7830587659
237UbiquitinationACGEVKLAFERKTCK
CCCHHHHHHCCCCCC
9.8729967540
251UbiquitinationKKVAIKIISKRKFAI
CHHHHHHHHCCCEEE
3.1829967540
260PhosphorylationKRKFAIGSAREADPA
CCCEEECCCCCCCCC
20.3128355574
267UbiquitinationSAREADPALNVETEI
CCCCCCCCCCHHHHH
16.5929967540
267 (in isoform 9)Ubiquitination-16.59-
273UbiquitinationPALNVETEIEILKKL
CCCCHHHHHHHHHHC
25.7229967540
279UbiquitinationTEIEILKKLNHPCII
HHHHHHHHCCCCEEE
51.5929967540
287UbiquitinationLNHPCIIKIKNFFDA
CCCCEEEEEECCCCH
27.9329967540
303 (in isoform 9)Phosphorylation-3.1124719451
322UbiquitinationGNKRLKEATCKLYFY
CCHHHHHHHHHHHHH
19.4029967540
327PhosphorylationKEATCKLYFYQMLLA
HHHHHHHHHHHHHHH
5.9224043423
329PhosphorylationATCKLYFYQMLLAVQ
HHHHHHHHHHHHHHH
4.5824043423
330UbiquitinationTCKLYFYQMLLAVQY
HHHHHHHHHHHHHHH
13.2229967540
337PhosphorylationQMLLAVQYLHENGII
HHHHHHHHHHHCCCC
11.9224043423
350 (in isoform 12)Phosphorylation-45.7729507054
356PhosphorylationKPENVLLSSQEEDCL
CHHHEEECCCCCCCE
26.3020873877
357PhosphorylationPENVLLSSQEEDCLI
HHHEEECCCCCCCEE
41.3920873877
372PhosphorylationKITDFGHSKILGETS
EEECCCCCHHCCCHH
23.0520713355
373UbiquitinationITDFGHSKILGETSL
EECCCCCHHCCCHHH
35.95-
378PhosphorylationHSKILGETSLMRTLC
CCHHCCCHHHHHHHH
25.9217698850
379PhosphorylationSKILGETSLMRTLCG
CHHCCCHHHHHHHHC
18.8328355574
381SulfoxidationILGETSLMRTLCGTP
HCCCHHHHHHHHCCC
2.8521406390
383PhosphorylationGETSLMRTLCGTPTY
CCHHHHHHHHCCCCC
16.6617698850
387PhosphorylationLMRTLCGTPTYLAPE
HHHHHHCCCCCCCCE
16.0930278072
389PhosphorylationRTLCGTPTYLAPEVL
HHHHCCCCCCCCEEE
30.8828464451
390PhosphorylationTLCGTPTYLAPEVLV
HHHCCCCCCCCEEEE
11.3228464451
401PhosphorylationEVLVSVGTAGYNRAV
EEEEEECCCCCCHHH
18.1122210691
415UbiquitinationVDCWSLGVILFICLS
HHHHHHHHHHHHHHH
4.1029967540
416 (in isoform 9)Ubiquitination-2.17-
429UbiquitinationSGYPPFSEHRTQVSL
HCCCCCCCCCCCCCH
37.4629967540
430 (in isoform 9)Phosphorylation-36.5724719451
432PhosphorylationPPFSEHRTQVSLKDQ
CCCCCCCCCCCHHHH
34.9215213307
435PhosphorylationSEHRTQVSLKDQITS
CCCCCCCCHHHHHHC
21.6418538787
437UbiquitinationHRTQVSLKDQITSGK
CCCCCCHHHHHHCCC
39.83-
441PhosphorylationVSLKDQITSGKYNFI
CCHHHHHHCCCCCCC
26.2923403867
442PhosphorylationSLKDQITSGKYNFIP
CHHHHHHCCCCCCCH
34.6123403867
443UbiquitinationLKDQITSGKYNFIPE
HHHHHHCCCCCCCHH
28.0229967540
444UbiquitinationKDQITSGKYNFIPEV
HHHHHCCCCCCCHHH
36.4729967540
456PhosphorylationPEVWAEVSEKALDLV
HHHHHHHHHHHHHHH
25.5315535844
458UbiquitinationVWAEVSEKALDLVKK
HHHHHHHHHHHHHHH
46.9029967540
465UbiquitinationKALDLVKKLLVVDPK
HHHHHHHHHCCCCCC
39.3029967540
472UbiquitinationKLLVVDPKARFTTEE
HHCCCCCCCCCCHHH
47.9729967540
478 (in isoform 9)Phosphorylation-37.9124719451
480 (in isoform 9)Ubiquitination-12.03-
487UbiquitinationALRHPWLQDEDMKRK
HHHCCCCCCHHHHHH
48.4529967540
494UbiquitinationQDEDMKRKFQDLLSE
CCHHHHHHHHHHHHH
41.6929967540
500PhosphorylationRKFQDLLSEENESTA
HHHHHHHHHCCCCCC
50.6023312004
501UbiquitinationKFQDLLSEENESTAL
HHHHHHHHCCCCCCH
65.8829967540
505PhosphorylationLLSEENESTALPQVL
HHHHCCCCCCHHHHH
30.4822210691
506PhosphorylationLSEENESTALPQVLA
HHHCCCCCCHHHHHC
26.4922210691
508 (in isoform 9)Ubiquitination-2.86-
515UbiquitinationLPQVLAQPSTSRKRP
HHHHHCCCCCCCCCC
33.6929967540
516PhosphorylationPQVLAQPSTSRKRPR
HHHHCCCCCCCCCCC
27.2525159151
517PhosphorylationQVLAQPSTSRKRPRE
HHHCCCCCCCCCCCC
38.9525159151
518PhosphorylationVLAQPSTSRKRPREG
HHCCCCCCCCCCCCC
39.8925850435
537UbiquitinationAETTKRPAVCAAVL-
CCCCCCCCCEEEEC-
17.0429967540
537 (in isoform 9)Ubiquitination-17.04-
559 (in isoform 9)Phosphorylation-24719451
560 (in isoform 9)Phosphorylation-27251275

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
19SPhosphorylationKinaseATMQ13315
PhosphoELM
19SPhosphorylationKinaseCHEK2O96017
GPS
26TPhosphorylationKinaseATMQ13315
PSP
26TPhosphorylationKinasePLK1P53350
PhosphoELM
28SPhosphorylationKinaseATMQ13315
PSP
33SPhosphorylationKinaseATMQ13315
PSP
33SPhosphorylationKinaseCHEK2O96017
GPS
35SPhosphorylationKinaseATMQ13315
PSP
35SPhosphorylationKinaseCHEK2O96017
GPS
50SPhosphorylationKinaseATMQ13315
PhosphoELM
62SPhosphorylationKinasePLK3Q9H4B4
Uniprot
68TPhosphorylationKinaseCHEK2O96017
GPS
68TPhosphorylationKinaseTTKP33981
PSP
68TPhosphorylationKinaseZAKQ9NYL2
PSP
68TPhosphorylationKinasePLK1P53350
PSP
68TPhosphorylationKinasePRKDCP78527
GPS
68TPhosphorylationKinaseATMQ13315
Uniprot
68TPhosphorylationKinaseATRQ13535
PSP
73SPhosphorylationKinasePLK3Q9H4B4
Uniprot
120SPhosphorylationKinaseCHEK2O96017
GPS
140SPhosphorylationKinaseCHEK2O96017
GPS
164SPhosphorylationKinasePLK1P53350
PSP
205TPhosphorylationKinasePLK1P53350
PSP
210SPhosphorylationKinasePLK1P53350
PSP
225TPhosphorylationKinaseCHEK2O96017
GPS
260SPhosphorylationKinaseCHEK2O96017
GPS
379SPhosphorylationKinaseCHEK2O96017
GPS
383TPhosphorylationKinaseCHEK2O96017
GPS
383TPhosphorylationKinasePRKDCP78527
GPS
387TPhosphorylationKinaseCHEK2O96017
GPS
387TPhosphorylationKinasePRKDCP78527
GPS
432TPhosphorylationKinaseCHEK2O96017
GPS
435SPhosphorylationKinaseCHEK2O96017
GPS
516SPhosphorylationKinaseCHEK2O96017
GPS
-KUbiquitinationE3 ubiquitin ligaseRNF8O76064
PMID:22266820
-KUbiquitinationE3 ubiquitin ligaseRCHY1Q96PM5
PMID:23449389
-KUbiquitinationE3 ubiquitin ligaseSIAH2O43255
PMID:26751770

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
68TPhosphorylation

10973490
73SPhosphorylation

16481012
379SPhosphorylation

18644861
383TPhosphorylation

11390408
387TPhosphorylation

11390408
456SPhosphorylation

17715138

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference
153Acetylation157 (4)ITrs17879961
  • Lung cancer
24880342
29059683

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
BRCA1_HUMANBRCA1physical
10724175
MSH2_HUMANMSH2physical
12447371
PLK3_HUMANPLK3physical
12242661
PLK1_HUMANPLK1physical
12493754
BRCA2_HUMANBRCA2physical
17525332
RAD50_HUMANRAD50physical
17525332
TP53B_HUMANTP53BP1physical
17525332
PSF2_HUMANGINS2physical
17525332
MUS81_HUMANMUS81physical
11741546
BRCA1_HUMANBRCA1physical
18804494
MPIP1_HUMANCDC25Aphysical
18480045
MDM2_HUMANMDM2physical
16943424
MDM4_HUMANMDM4physical
16163388
FOXM1_HUMANFOXM1physical
17101782
MPIP3_HUMANCDC25Cphysical
16705183
REV3L_HUMANREV3Lphysical
18622427
P53_HUMANTP53physical
12810724
MPIP1_HUMANCDC25Aphysical
12759351
AATF_HUMANAATFphysical
17157788
P53_HUMANTP53physical
10673501
CHK2_HUMANCHEK2physical
11901158
CHK2_HUMANCHEK2physical
12024051
MPIP3_HUMANCDC25Cphysical
12024051
2ABB_HUMANPPP2R2Bphysical
15380617
2A5A_HUMANPPP2R5Aphysical
15380617
2A5D_HUMANPPP2R5Dphysical
15380617
2A5G_HUMANPPP2R5Cphysical
15380617
2A5E_HUMANPPP2R5Ephysical
15380617
2A5B_HUMANPPP2R5Bphysical
15380617
2AAA_HUMANPPP2R1Aphysical
15380617
PP2AA_HUMANPPP2CAphysical
15380617
TIF1B_HUMANTRIM28physical
22496453
PSME3_HUMANPSME3physical
19556897
LATS2_HUMANLATS2physical
21118956
MDM2_HUMANMDM2physical
19176998
KAT2B_HUMANKAT2Bphysical
19176998
PML_HUMANPMLphysical
12402044
MPIP3_HUMANCDC25Cphysical
12402044
BRCA2_HUMANBRCA2physical
14623252
BRCA1_HUMANBRCA1physical
12438214
MDM2_HUMANMDM2physical
15862297
P53_HUMANTP53physical
15862297
UBR5_HUMANUBR5physical
17074762
P53_HUMANTP53physical
10710310
RB_HUMANRB1physical
17380128
BRCA1_HUMANBRCA1physical
17380128
IMA1_HUMANKPNA2physical
12909615
CHK2_HUMANCHEK2physical
12909615
MPIP3_HUMANCDC25Cphysical
12909615
A4_HUMANAPPphysical
21832049
STRAP_HUMANSTRAPphysical
18833288
P53_HUMANTP53physical
18833288
CHK2_HUMANCHEK2physical
12676583
MPIP1_HUMANCDC25Aphysical
12676583
CUL4A_HUMANCUL4Aphysical
23109433
CUL1_HUMANCUL1physical
23109433
MPIP3_HUMANCDC25Cphysical
11438675
CHK2_HUMANCHEK2physical
11438675
MPIP3_HUMANCDC25Cphysical
10744722
ELAV1_HUMANELAVL1physical
17317627
MPIP1_HUMANCDC25Aphysical
11298456
ZN363_HUMANRCHY1physical
23449389
VHL_HUMANVHLphysical
22071692
CHK2_HUMANCHEK2physical
16794575
NR4A1_HUMANNR4A1physical
21988832
RPAB5_HUMANPOLR2Lphysical
21988832
SIR1_HUMANSIRT1physical
25361978
CCAR2_HUMANCCAR2physical
25361978
CHK2_HUMANCHEK2physical
25361978
MPIP3_HUMANCDC25Cphysical
25361978
PSME3_HUMANPSME3physical
25361978
BEX1_HUMANBEX1physical
25640309
CCL5_HUMANCCL5physical
25640309
CAD13_HUMANCDH13physical
25640309
CP17A_HUMANCYP17A1physical
25640309
DIRA3_HUMANDIRAS3physical
25640309
FA84B_HUMANFAM84Bphysical
25640309
HXC6_HUMANHOXC6physical
25640309
IL24_HUMANIL24physical
25640309
ITIH5_HUMANITIH5physical
25640309
KLK7_HUMANKLK7physical
25640309
KLK9_HUMANKLK9physical
25640309
LYPD3_HUMANLYPD3physical
25640309
PRD14_HUMANPRDM14physical
25640309
HOP2_HUMANPSMC3IPphysical
25640309
RHBT2_HUMANRHOBTB2physical
25640309
BRE1A_HUMANRNF20physical
25640309
ST14_HUMANST14physical
25640309
NSD3_HUMANWHSC1L1physical
25640309
BAALC_HUMANBAALCphysical
25640309
ENOA_HUMANENO1physical
25640309
GNAS3_HUMANGNASphysical
25640309
GNAS2_HUMANGNASphysical
25640309
ALEX_HUMANGNASphysical
25640309
GNAS1_HUMANGNASphysical
25640309
HMGN1_HUMANHMGN1physical
25640309
ADT3_HUMANSLC25A6physical
25640309
ANM2_HUMANPRMT2physical
25640309
STMN1_HUMANSTMN1physical
25640309
TLR3_HUMANTLR3physical
25640309
SIAH2_HUMANSIAH2physical
26751770
ERBB2_HUMANERBB2genetic
28319113
KMT2D_HUMANKMT2Dgenetic
28319113
WEE1_HUMANWEE1genetic
27453043
CHK1_HUMANCHEK1genetic
27453043
CDC6_HUMANCDC6genetic
27453043
CDC73_HUMANCDC73genetic
27453043
BLM_HUMANBLMgenetic
27453043
RFC1_HUMANRFC1genetic
27453043
RAD17_HUMANRAD17genetic
27453043
FZR1_HUMANFZR1genetic
27453043
ATAD5_HUMANATAD5genetic
27453043
L2GL1_HUMANLLGL1genetic
27453043
CC14A_HUMANCDC14Agenetic
27453043
RS10_HUMANRPS10genetic
27453043
WRN_HUMANWRNgenetic
27453043
ATR_HUMANATRgenetic
27453043
DAAM1_HUMANDAAM1genetic
27453043
TITIN_HUMANTTNgenetic
27453043
BRD4_HUMANBRD4genetic
27453043
MPIP3_HUMANCDC25Cphysical
11053450
PPM1D_HUMANPPM1Dphysical
16311512
MPIP3_HUMANCDC25Cphysical
16311512

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
609265Li-Fraumeni syndrome 2 (LFS2)
176807Prostate cancer (PC)
259500Osteogenic sarcoma (OSRC)
114480Breast cancer (BC)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CHK2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Regulation of Chk2 ubiquitination and signaling throughautophosphorylation of serine 379.";
Lovly C.M., Yan L., Ryan C.E., Takada S., Piwnica-Worms H.;
Mol. Cell. Biol. 28:5874-5885(2008).
Cited for: FUNCTION IN APOPTOSIS, AUTOPHOSPHORYLATION AT SER-379, MUTAGENESIS OFSER-379, UBIQUITINATION, AND INTERACTION WITH CUL1.
"Stability of checkpoint kinase 2 is regulated via phosphorylation atserine 456.";
Kass E.M., Ahn J., Tanaka T., Freed-Pastor W.A., Keezer S., Prives C.;
J. Biol. Chem. 282:30311-30321(2007).
Cited for: FUNCTION IN APOPTOSIS, PHOSPHORYLATION AT SER-456, UBIQUITINATION, ANDMUTAGENESIS OF SER-456.
"Priming phosphorylation of Chk2 by polo-like kinase 3 (Plk3) mediatesits full activation by ATM and a downstream checkpoint in response toDNA damage.";
Bahassi el M., Myer D.L., McKenney R.J., Hennigan R.F.,Stambrook P.J.;
Mutat. Res. 596:166-176(2006).
Cited for: PHOSPHORYLATION AT SER-62; THR-68 AND SER-73, AND MUTAGENESIS OFSER-73.
"Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1phosphatase.";
Fujimoto H., Onishi N., Kato N., Takekawa M., Xu X.Z., Kosugi A.,Kondo T., Imamura M., Oishi I., Yoda A., Minami Y.;
Cell Death Differ. 13:1170-1180(2006).
Cited for: PHOSPHORYLATION AT THR-68, AND DEPHOSPHORYLATION AT THR-68 BY PPM1D.
"The stress kinase MRK contributes to regulation of DNA damagecheckpoints through a p38gamma-independent pathway.";
Tosti E., Waldbaum L., Warshaw G., Gross E.A., Ruggieri R.;
J. Biol. Chem. 279:47652-47660(2004).
Cited for: ENZYME REGULATION, PHOSPHORYLATION AT THR-68 BY MLTK, AND MUTAGENESISOF THR-68 AND ASP-368.
"The hCds1 (Chk2)-FHA domain is essential for a chain ofphosphorylation events on hCds1 that is induced by ionizingradiation.";
Lee C.H., Chung J.H.;
J. Biol. Chem. 276:30537-30541(2001).
Cited for: AUTOPHOSPHORYLATION AT THR-383 AND THR-387, AND MUTAGENESIS OF THR-383AND THR-387.

TOP